- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 31-08-2026: Press Release
31-08-2026 | 10:43 am
31-08-2026 | 10:43 am
Zydus reported positive Phase II(b) trial results for Saroglitazar Mg in MASH. The study met its primary endpoint, showing resolution of steatohepatitis without worsening fibrosis, marking a key milestone for this significant unmet global health need.
No comments yet. Be the first to comment!